U.S.-CHINA PHARMA taking place on May 23-24, at the Hub Cira Centre in Philadelphia, will assemble hundreds of senior pharmaceutical and biotech managers from U.S. and China to explore key issues in building economic opportunities between these two markets. 

Participants will have the unique opportunity to meet face-to-face with executives who are looking for R&D partnership opportunities throughout North America and China, all in one place.

• BAY CITY CAPITAL, Dr. Charles Hsu, Venture Partner
• BEIGENE LTD, Dr. Pearl Huang, Founder and CSO
• BRISTOL-MYERS SQUIBB, Dr. Jingsong Wang, Director, Discovery Medicine & Clinical Pharmacology
• CROWN BIOSCIENCE, Dr. Yiyou Chen, CSO
• CRV BIOTECH INC, Xiao Yang, President
• DYNAMIS THERAPEUTICS AND DYNAMIS SKIN SCIENCE, Dr. Annette Tobia, Founder and CEO
• FOUNTAIN MEDICAL DEVELOPMENT, Dr. Joanne Jiang, Co-Founder, VP, Business Development and Project Management
• HARVARD SCHOOL OF PUBLIC HEALTH, Dr. David Christiani, Elkan Blout Professor of Environmental Genetics, Department of Environmental Health, Department of Epidemiology
• HENGRUI PHARMACEUTICALS (CHINA), Dr. Mike Liu, Head of Global Business Development
• INSIGHT STRATEGY ADVISORS, Cyrus A. Chowdhury, VP, Global Market Access
• JOHN MARSHALL LAW SCHOOL, Prof. Benjamin Liu, Assistant Professor, China IP Resource Center
• LIMR CHEMICAL GENOMICS CENTER, Dr. Melvin Reichman, Director
• LOCUST WALK PARTNERS, Geoff Meyerson, Founder and Managing Director
• MERCK, Dr. Jing-Shan (Jennifer) Hu, Director of Licensing & External Research (Mainland China, Hong Kong, & Taiwan)
• MERCK, Wim Vandenhouweele, Executive Director, Global Vaccines & Commercial Development
• MORGAN LEWIS & BOCKIUS, Wenseng "Wendy" Pan, Ph.D., Associate
• MORRISON & FOERSTER, Dr. Peng Chen, Partner
• NOVARTIS VACCINES & DIAGNOSTICS, Drew Natenshon, Head US Research Strategy and Operations
• ORRICK HERRINGTON & SUTCLIFFE (BEIJING), Dr. Xiang Wang, Partner, Intellectual Property
• PFIZER, Dr. Evan Loh, SVP, WRD Development and Strategic Operations
• PFIZER, Dr. Yuan-Hua Ding, Sr. Director & Head of External R&D Innovation - Asia
• PFIZER ONCOLOGY, Dr. Wei Zhou, Director, Molecular Epidemiology Research, Global Outcome Research
• SAFEGUARD SCIENTIFICS, Wei Zhang, Ph.D., Principal
• SR ONE, Rajeev Dadoo, Partner
• TAIGEN (TAIWAN), Dr. John Jin, VP Business Development
• UNIVERSITY CITY SCIENCE CENTER, Dr. Christopher Laing, VP, Science and Technology
• UNIVERSITY OF TEXAS, Dr. Qingyi Wei, Professor of Epidemiology, MD Anderson Cancer Center
• UNIVERSITY OF WISCONSIN, Dr. George Wilding, Director, UWCCC; Assistant Dean for Oncology, Anderson Professor of Medicine, School of Medicine and Public Health